These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1907801)

  • 1. Utility of a transdermal delivery system for antihypertensive therapy. Part 1.
    Sclar DA; Skaer TL; Chin A; Okamoto MP; Gill MA
    Am J Med; 1991 Jul; 91(1A):50S-56S. PubMed ID: 1907801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of a transdermal delivery system for antihypertensive therapy. Part 2.
    Sclar DA; Skaer TL; Chin A; Okamoto MP; Gill MA
    Am J Med; 1991 Jul; 91(1A):57S-60S. PubMed ID: 1907802
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of pharmaceutical formulation for antihypertensive therapy on health service utilization.
    Skaer TL; Sclar DA; Robison LM; Chin A; Gill MA; Okamoto MP; Nakahiro RK
    Clin Ther; 1993; 15(4):715-25; discussion 714. PubMed ID: 8221822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antihypertensive formulation on health service expenditures.
    Sclar DA; Skaer TL; Robison LM; Chin A; Okamoto MP; Nakahiro RK; Gill MA
    Clin Auton Res; 1993 Dec; 3(6):363-8. PubMed ID: 8193522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal clonidine as an adjunct to sustained-release diltiazem in the treatment of mild-to-moderate hypertension.
    Lueg MC; Herron J; Zellner S
    Clin Ther; 1991; 13(4):471-81. PubMed ID: 1933999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy.
    Dickson M; Plauschinat CA
    Am J Cardiovasc Drugs; 2008; 8(1):45-50. PubMed ID: 18303937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic adherence in the elderly: transdermal clonidine compared to oral verapamil for hypertension.
    Burris JF; Papademetriou V; Wallin JD; Cook ME; Weidler DJ
    Am J Med; 1991 Jul; 91(1A):22S-28S. PubMed ID: 1867225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pharmaceutical formulation for diltiazem on health care expenditures for hypertension.
    Skaer TL; Sclar DA; Robison LM; Markowski DJ; Won JK
    Clin Ther; 1993; 15(5):905-11. PubMed ID: 8269458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translating safety, efficacy and compliance into economic value for controlled release dosage forms.
    Cramer MP; Saks SR
    Pharmacoeconomics; 1994 Jun; 5(6):482-504. PubMed ID: 10150160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of a sustained-release formulation for antihypertensive therapy.
    Skaer TL; Sclar DA; Markowski DJ; Won JK
    J Hum Hypertens; 1993 Oct; 7(5):519-22. PubMed ID: 8263896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal clonidine as an adjunct to enalapril: an evaluation of efficacy and patient compliance.
    Weidler D; Wallin JD; Cook E; Dillard D; Lewin A
    J Clin Pharmacol; 1992 May; 32(5):444-9. PubMed ID: 1587962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with transdermal clonidine in African-American and Hispanic-American patients with hypertension: evaluation from a 12-week prospective, open-label clinical trial in community-based clinics.
    Dias VC; Tendler B; Oparil S; Reilly PA; Snarr P; White WB
    Am J Ther; 1999 Jan; 6(1):19-24. PubMed ID: 10423643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment with transdermal clonidine in mild hypertension.
    Fillingim JM; Matzek KM; Hughes EM; Johnson PA; Sharon GS
    Clin Ther; 1989; 11(3):398-408. PubMed ID: 2743374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal administration of clonidine: a new approach to antihypertensive therapy.
    Burris JF; Mroczek WJ
    Pharmacotherapy; 1986; 6(1):30-4. PubMed ID: 3952004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind comparison of transdermal clonidine and oral captopril in essential hypertension.
    McMahon FG; Jain AK; Vargas R; Fillingim J
    Clin Ther; 1990; 12(2):88-100. PubMed ID: 2191779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of transdermal clonidine in chronic hemodialysis patients.
    Rosansky SJ; Johnson KL; McConnell J
    Clin Nephrol; 1993 Jan; 39(1):32-6. PubMed ID: 8428405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of transdermal clonidine and oral atenolol on acute exercise performance and response to aerobic conditioning in subjects with hypertension.
    Davies SF; Graif JL; Husebye DG; Maddy MM; McArthur CD; Path MJ; O'Connell MB; Iber C; Davidman M
    Arch Intern Med; 1989 Jul; 149(7):1551-6. PubMed ID: 2525897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal and oral clonidine.
    Lilja M; Juustila H; Sarna S; Jounela AJ
    Ann Med; 1991 Aug; 23(3):265-9. PubMed ID: 1930916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The USA experience with the clonidine transdermal therapeutic system.
    Burris JF
    Clin Auton Res; 1993 Dec; 3(6):391-6. PubMed ID: 8193527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
    Ishii R; Tagawa T; Ishida T; Naruse T
    Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.